Lifevantage Debt to Equity Ratio 2010-2024 | LFVN

Current and historical debt to equity ratio values for Lifevantage (LFVN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Lifevantage debt/equity for the three months ending March 31, 2024 was 0.00.
Lifevantage Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-03-31 $0.04B $0.03B 1.29
2023-12-31 $0.04B $0.03B 1.30
2023-09-30 $0.04B $0.03B 1.27
2023-06-30 $0.03B $0.04B 0.91
2023-03-31 $0.03B $0.03B 1.01
2022-12-31 $0.04B $0.03B 1.13
2022-09-30 $0.04B $0.03B 1.12
2022-06-30 $0.04B $0.03B 1.24
2022-03-31 $0.04B $0.03B 1.12
2021-12-31 $0.04B $0.04B 1.08
2021-09-30 $0.04B $0.04B 1.03
2021-06-30 $0.04B $0.04B 1.14
2021-03-31 $0.04B $0.04B 1.11
2020-12-31 $0.04B $0.04B 1.10
2020-09-30 $0.04B $0.03B 1.06
2020-06-30 $0.03B $0.03B 0.77
2020-03-31 $0.02B $0.03B 0.83
2019-12-31 $0.03B $0.03B 0.89
2019-09-30 $0.03B $0.03B 0.89
2019-06-30 $0.03B $0.03B 1.03
2019-03-31 $0.03B $0.03B 1.19
2018-12-31 $0.03B $0.02B 1.57
2018-09-30 $0.03B $0.02B 1.21
2018-06-30 $0.03B $0.02B 1.33
2018-03-31 $0.03B $0.02B 1.64
2017-12-31 $0.03B $0.02B 1.77
2017-09-30 $0.03B $0.02B 1.84
2017-06-30 $0.03B $0.02B 2.12
2017-03-31 $0.03B $0.01B 2.36
2016-12-31 $0.03B $0.02B 2.21
2016-09-30 $0.04B $0.01B 2.54
2016-06-30 $0.04B $0.01B 3.78
2016-03-31 $0.04B $0.01B 3.99
2015-12-31 $0.04B $0.01B 5.41
2015-09-30 $0.04B $0.01B 7.65
2015-06-30 $0.04B $0.00B 10.96
2015-03-31 $0.04B $0.00B 15.58
2014-12-31 $0.05B $0.01B 10.23
2014-09-30 $0.05B $0.01B 6.88
2014-06-30 $0.05B $0.00B 12.53
2014-03-31 $0.07B $0.00B 24.78
2013-12-31 $0.06B $-0.00B -116.68
2013-09-30 $0.02B $0.04B 0.55
2013-06-30 $0.02B $0.03B 0.64
2013-03-31 $0.02B $0.04B 0.56
2012-12-31 $0.02B $0.04B 0.57
2012-09-30 $0.02B $0.03B 0.47
2012-06-30 $0.02B $0.03B 0.57
2012-03-31 $0.01B $0.02B 0.48
2011-12-31 $0.02B $0.01B 1.64
2011-09-30 $0.03B $-0.02B -2.06
2011-06-30 $0.03B $-0.02B -1.60
2011-03-31 $0.02B $-0.01B -1.73
2010-12-31 $0.01B $-0.01B -2.63
2010-09-30 $0.02B $-0.01B -1.61
2010-06-30 $0.02B $-0.02B -1.39
2010-03-31 $0.02B $-0.01B -1.50
2009-12-31 $0.01B $-0.01B -1.88
2009-09-30 $0.01B $-0.01B -1.86
2009-06-30 $0.01B $-0.01B -1.84
2009-03-31 $0.01B $-0.00B -2.35
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.091B $0.213B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $71.803B 20.15
Becton Dickinson (BDX) United States $67.876B 19.20
West Pharmaceutical Services (WST) United States $24.549B 44.00
Cardinal Health (CAH) United States $23.385B 13.37
Align Technology (ALGN) United States $19.876B 38.38
Cooper (COO) United States $19.232B 29.10
Labcorp (LH) United States $17.310B 14.90
Henry Schein (HSIC) United States $9.380B 16.69
DENTSPLY SIRONA (XRAY) United States $5.855B 15.16
Merit Medical Systems (MMSI) United States $4.783B 26.21
CONMED (CNMD) United States $2.306B 20.91
Patterson (PDCO) United States $2.223B 10.65
STAAR Surgical (STAA) United States $2.089B 80.21
Atrion (ATRI) United States $0.794B 42.41
Pro-Dex (PDEX) United States $0.065B 33.02
Biolase (BIOL) United States $0.005B 0.00